Mingyue Optical Lens Co Ltd
SZSE:301101
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
20.18
48.88
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Mingyue Optical Lens Co Ltd
Revenue
Mingyue Optical Lens Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mingyue Optical Lens Co Ltd
SZSE:301101
|
Revenue
¥748.7m
|
CAGR 3-Years
12%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Revenue
¥13B
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
|
Revenue
¥951.2m
|
CAGR 3-Years
52%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Revenue
¥4.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Revenue
¥8.2B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Revenue
¥3.9B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
Mingyue Optical Lens Co Ltd
Glance View
In the dynamic landscape of the optical industry, Mingyue Optical Lens Co Ltd stands out as an influential player, weaving technology with craftsmanship to redefine vision solutions. Established in 1997, the company has steadily expanded its footprint across China and beyond, driven by a commitment to innovation and quality. Mingyue specializes in the research, development, and manufacturing of optical lenses, utilizing state-of-the-art facilities to produce a wide range of products, from single vision and bifocal lenses to advanced progressive and blue light-blocking lenses. The company's strength lies not just in its cutting-edge production technology but in its deep understanding of consumer needs, which allows it to create lenses that offer clarity, comfort, and protection. By investing in R&D, Mingyue stays ahead in the competitive eyewear market and continually enhances its product portfolio to meet the evolving demands of both opticians and consumers. At the heart of Mingyue Optical's business model is a vertically integrated approach that ensures quality control and cost efficiency from raw material sourcing to final product distribution. This approach enables the company to maintain pricing competitiveness while upholding strict quality standards, fostering trust and loyalty among its customer base. Mingyue's revenue streams primarily flow from the wholesale distribution of its lenses to optical retailers, eye care professionals, and direct partnerships with eyewear brands. Additionally, the company leverages its strong distribution network and strategic partnerships to penetrate international markets, contributing significantly to its growth and profitability. By constantly aligning its operations with market trends and consumer preferences, Mingyue Optical continues to thrive, positioning itself as a significant force in the global optics industry.
See Also
What is Mingyue Optical Lens Co Ltd's Revenue?
Revenue
748.7m
CNY
Based on the financial report for Dec 31, 2023, Mingyue Optical Lens Co Ltd's Revenue amounts to 748.7m CNY.
What is Mingyue Optical Lens Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
8%
Over the last year, the Revenue growth was 20%. The average annual Revenue growth rates for Mingyue Optical Lens Co Ltd have been 12% over the past three years , 8% over the past five years .
You don't have any saved screeners yet